Bladder Cancer - Results from #20

Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study. May 31, 2021

Oncologic Surveillance for Variant Histology Bladder Cancer after Radical Cystectomy. May 31, 2021

The prognostic effect of metastasis patterns on overall survival in patients with distant metastatic bladder cancer: a SEER population-based analysis. May 28, 2021

Preoperative Serum Gamma-Glutamyltransferase as a Prognostic Biomarker in Patients Undergoing Radical Cystectomy for Bladder Cancer. May 28, 2021

Impact of preoperative plasma levels of interleukin 6 and interleukin 6 soluble receptor on disease outcomes after radical cystectomy for bladder cancer. May 27, 2021

Cost-Effectiveness of Atezolizumab Plus Chemotherapy as First-Line Therapy for Metastatic Urothelial Cancer. May 27, 2021

TERT mutation and the p53 pathway in T1 urinary bladder cancer. May 26, 2021

Impact of Perioperative Immunonutrition on Complications in Patients Undergoing Radical Cystectomy: A Retrospective Analysis. May 26, 2021

Treatment Outcomes and Estimated Costs Associated with BCG Therapy for Patients with High-Risk Non-Muscle-Invasive Bladder Cancer - Expert Commentary May 25, 2021

Guideline adherence for radical cystectomy significantly affects survival outcomes in non-muscle-invasive bladder cancer patients. May 25, 2021

Barriers to single-dose intravesical chemotherapy in non-muscle invasive bladder cancer: what's the problem? May 25, 2021

Green-light laser en bloc resection versus conventional transurethral resection for initial non-muscle-invasive bladder cancer: A randomized controlled trial. May 24, 2021

Adjuvant pembrolizumab in genomically selected high-risk patients with muscle-invasive bladder cancer. May 24, 2021

Proteomic comparison between different tissue preservation methods for identification of promising biomarkers of urothelial bladder cancer. May 24, 2021

Intra-corporeal robot-assisted versus open radical cystectomy: a propensity score-matched analysis comparing perioperative and long-term survival outcomes and recurrence patterns. May 21, 2021

Perioperative pembrolizumab therapy in muscle-invasive bladder cancer: Phase III KEYNOTE-866 and KEYNOTE-905/EV-303. May 21, 2021

Clinical Outcomes of Platinum-ineligible Patients with Advanced Urothelial Carcinoma Treated With First-line PD1/L1 Inhibitors. May 21, 2021

Risk factors for residual disease at re-TUR in a large cohort of T1G3 patients. May 20, 2021

The HELENA study: Hexvix®-TURB vs. white-light TURB followed by intravesical adjuvant chemotherapy-a prospective randomized controlled open-label multicenter non-inferiority study. May 20, 2021

Impact of perioperative blood transfusions on oncologic outcomes after radical cystectomy: A systematic review and meta-analysis of comparative studies. May 19, 2021

Page 2 of 396